(0)
-
- Overview
- Services
Target-specific Assays
- Kinase Assays
- Epigenetic Assays
- RAS-related Assays
- Immune Checkpoint Assays
- Targeted Protein Degradation Assays
- PARP Assays
- Phosphatase Assays
- Protease Assays
- Apoptosis Pathway Assays
- Metabolic Pathway Assays
- Phosphodiesterase Assays (PDE)
- Ubiquitin-Proteasome Pathway Assays
- Ion Channel Assays
- GPCR Assays
- Nuclear Receptor Assays
- COVID-19-related Assays
- Additional Targets
- Protein Production and Assay Development
- Custom Antibody Services
- Custom Peptide Services
Cell-Based Assays
- Target-Specific Cell-based Assays
- 2D Cell-based Assays
- 3D Cell-based Assays
- Cell Line Generation
- Assay Platforms
Biophysical Assays
- Surface Plasmon Resonance (SPR)
- Isothermal Titration Calorimetry (ITC)
- Microscale Thermophoresis (MST)
- Thermal Shift Assay (TSA)
ADME & Safety
In Vivo Pharmacology
- Xenograft Tumor Models
- In Vivo Hollow Fiber Model
- In Vivo Kinase Activity Models
- Immuno-Oncology Tumor Models
Immuno-Oncology Platform
- Immuno-Oncology Tumor Models
- Immuno-Oncology Assays
Biomarker Discovery
- Genetic Biomarkers
- Protein Biomarkers
- Phenotypic Biomarkers
- Immunophenotyping
Bioprocessing
- Products
- Resources
- Company
- Contact